Clinical InterestsDiabetic Eye CareRetina
Refer a Friend
Enter an email address below to share the provider's page with someone you know.
ResourcesAge-Related Macular Degeneration Amsler Grid Central Serous Retinopathy Cystoid Macular Edema Diabetic Macular Edema Epiretinal Membrane and Macular Pucker Flashes and Floaters Macular Hole Ultra-wide Field Retinal Photography and Angiography Ocular Tumors The Retina Retinal Tears and Detachments Retinal Vein Occlusion Vitrectomy Surgery
Dr. Andrew Antoszyk is a board-certified Ophthalmologist who specializes in medical and surgical diseases of the retina and vitreous, macular degeneration, diabetic retinopathy, retinovascular disease, and retinal detachments in the Charlotte and Statesville, NC areas. He has authored and co-authored 39 peer-reviewed papers and three book chapters, and has been involved in numerous clinical trials and research programs. When he is not working, he loves to spend time with his family and is an avid golfer and tennis player. He loves to root for the Duke sports teams and the Carolina Panthers.
Education & Fellowship
University of Albany, 1979
New York Medical College, 1983
Duke University Medical Center, 1984
Ophthalmology, Duke University Eye Center, 1987
Vitreoretinal Diseases, Duke University Eye Center, 1989
Associations & Memberships
Board Certified by:
- American Board of Ophthalmology
- Alpha Omega Alpha – medical honor society
- American Board of Ophthalmology -Examiner and Mentor
- American Academy of Ophthalmology -Fellow
- Vice Chair of Diabetic Retinopathy Clinical Research Network
- Society of Heed Fellows
- American Society of Retina Specialists
- Association for Research in Vision and Ophthalmology
- North Carolina Medical Society
- Mecklenburg County Medical Society
- North Carolina Society of Eye Physicians and Surgeons
- Retina Society
Assistant Professor of Surgery at the Uniformed Services University for the Health Sciences
Assistant Consulting Professor at the Duke University Eye Center
MIVS - Micro-Incisional Vitreoretinal Surgery: Dr. Antoszyk specializes in micro-incisional vitreoretinal surgery in the management of retinal detachments, epiretinal membranes and complications of diabetic retinopathy. This technique utilizes instruments ranging from 27-23 gauge in diameter and is associated with minimal post-operative discomfort, faster visual recovery and prompt return to normal activity.
Alpha Omega Alpha
National Research Service Award
Navy Achievement Medal
National Defense Medal
Defense Meritorious Service medal
Resident Teaching Award
Best Doctors In America, 2003-2018
Charlotte Business Journal Best Doctors List, 2015-2016
American Society of Retina Specialists Honor Award, 2016
Business North Carolina Best Doctors, 2016-2018
Dr. Antoszyk authored and co-authored more than 35 peer-reviewed papers and book chapters including: “Aflibercept Bevacizumab or Ranibizumab for Diabetic Macular Edema” published in the New England Journal of Medicine, February 2015.
He is also the principal investigator for numerous clinical trials and currently investigating new treatments for wet and dry age-related macular degeneration, diabetic retinopathy and retinal vein occlusions. This includes "Effect of Adding Dexamethasone to Continue Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema," published in the Journal of the American Medical Association, Nov. 11, 2017.
Dr. Antoszyk was also involved in developing an Angiogenesis Foundation white paper on Improving Long-Term Patient Outcomes for Exudative Age-Related Macular Degeneration (AMD).
Dr. Antoszyk and Dr. Omar Punjabi co-authored a paper about a rare case of a maggot that had found its way into the eye, and was swimming under the retina. Dr. Antoszyk immediately lasered and killed it in the office and the patient's eyesight was restored. Dr. Punjabi presented the case at the 2018 American Society of Retina Specialists meeting. It was described as one of the best cases of the year. The paper, "'Pacman' Invasion of the Retina," was published in Retina Today, November/December 2018.